Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

Author(s):
Sims, A.H.; Zweemer, A.J.M.; Nagumo, Y.; Faratian, D.; Muir, M.; Dodds, M.; Um, I.; Kay, C.; Hasmann, M.; Harrison, D.J.; Langdon, S.P.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-05-22
Language
English
Is part of
British Journal of Cancer (2012), Vol. 106, p. 1779-1789
hdl
1887/121979
doi
10.1038/bjc.2012.176